Skip to main content
. 2023 Oct 30;66(21):14787–14814. doi: 10.1021/acs.jmedchem.3c01385

Figure 7.

Figure 7

Dual Sirt2/HDAC6 inhibitors increase α-tubulin acetylation levels in PC-3M-luc prostate cancer cells. Cells were treated with 20 μM of Sirt2 inhibitor or DMSO (vehicle) for 5 h before imaging. Representative images (n = 4) show acetylation levels of α-tubulin in red and the DAPI-stained nuclei in blue. Scale bar represents 24 μm.